Drugs / APL180
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00907998 | Jun → Oct 2009 | coronary artery disorder | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00568594 | Nov 2007 → Sep 2009 | coronary artery disorder | Novartis | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00751608 Comparator | Sep 2006 → Feb 2009 | familial hypercholesterolemia | Novartis Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APL180 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00568594 ↗ |
| Route | Intravenous | “single intravenous infusion” NCT00568594 ↗ |